Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rangering i aksjer #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aksjekurs
$64.97
Sist synkronisert: 2024-05-20
Markedsverdi
$1.97B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Kategori

Aksjeprishistorikk for Alpine Immune Sciences, Inc. (ALPN)
Høyeste sluttskurs: $64.81 den 2024-05-01

Laveste sluttskurs: $59.56 den 2015-06-01
Aksjeprishistorikk for Alpine Immune Sciences, Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 256.53%
2023 178.29%
2022 -49.70%
2021 1.90%
2020 264.34%
2019 -23.56%
2018 -58.58%
2017 29.87%
2016 -73.99%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH